TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs

Mark Alles, Executive Chairman of TORL BioTherapeutics, LLC (TORL) and former Chairman and CEO of Celgene Corporation has been appointed TORL's Chairman and CEO. Mark brings more than 35 years of global biopharmaceutical experience, and will lead TORL as i... Biopharmaceuticals, Oncology, Personnel TORL BioTherapeutics, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news